Predictors of alternative antidepressant agent initiation among U. S. veterans diagnosed with depression
dc.contributor.author | Kim, Hyungjin Myra | en_US |
dc.contributor.author | Zivin, Kara | en_US |
dc.contributor.author | Ganoczy, Dara | en_US |
dc.contributor.author | Pfeiffer, Paul N. | en_US |
dc.contributor.author | Hoggatt, Katherine | en_US |
dc.contributor.author | McCarthy, John F. | en_US |
dc.contributor.author | Downing, Karen E. | en_US |
dc.contributor.author | Valenstein, Marcia | en_US |
dc.date.accessioned | 2010-10-06T14:57:06Z | |
dc.date.available | 2011-03-01T16:26:44Z | en_US |
dc.date.issued | 2010-10 | en_US |
dc.identifier.citation | Kim, Hyungjin Myra; Zivin, Kara; Ganoczy, Dara; Pfeiffer, Paul; Hoggatt, Katherine; McCarthy, John F.; Downing, Karen; Valenstein, Marcia (2010). "Predictors of alternative antidepressant agent initiation among U. S. veterans diagnosed with depression." Pharmacoepidemiology and Drug Safety 19(10): 1049-1056. <http://hdl.handle.net/2027.42/78075> | en_US |
dc.identifier.issn | 1053-8569 | en_US |
dc.identifier.issn | 1099-1557 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/78075 | |
dc.description.abstract | OBJECTIVES Naturalistic studies comparing differences in risks across antidepressant agents must take into account factors which influence selection of specific agents and may be associated with outcomes. We examined predictors of antidepressant choice among VA patients treated for depression. METHODS Retrospective cohort study of VA patients with depression diagnoses and a new start of one of the seven most commonly prescribed antidepressant agents between 1 April 1999 and 30 September 2004 ( n = 502 179). We examined the relationship between patient and facility characteristics and new starts of bupropion, citalopram, fluoxetine, mirtazapine, paroxetine, sertraline, and venlafaxine. We also examined factors associated with new starts only among patients starting selective serotonin reuptake inhibitors (SSRIs). RESULTS Thirty-three percent of patients starting mirtazapine had at least three outpatient mental health visits in the prior year, compared to ≤24% of patients prescribed other antidepressants. Patients starting mirtazapine were also most likely to have received at least two other psychotropic medications in the prior year. Of the four SSRIs, 40% of the patients receiving sertraline and only 31% of those receiving fluoxetine were 65 years or older. A comorbid anxiety disorder (other than post-traumatic stress disorder) was diagnosed in 21% of paroxetine patients compared with ≤15% of other SSRI patients. CONCLUSION Choice of antidepressant medication for depressed VA patients was associated with important differences in demographic and clinical variables, including psychiatric illness severity, older age, and likelihood of a comorbid anxiety disorder. These findings emphasize the importance of controlling for selection bias when using observational data to compare risks from or effect of mental health treatments. Copyright © 2010 John Wiley & Sons, Ltd. | en_US |
dc.format.extent | 92686 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | John Wiley & Sons, Ltd. | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Epidemiology, Biostatistics and Public Health | en_US |
dc.title | Predictors of alternative antidepressant agent initiation among U. S. veterans diagnosed with depression | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Veterans Affairs, Ann Arbor Center of Excellence (COE), Serious Mental Illness Treatment Resource and Evaluation Center (SMITREC), Ann Arbor, Michigan ; Center for Statistical Consultation and Research, University of Michigan, Ann Arbor, Michigan ; 3555 Rackham, CSCAR, University of Michigan, Ann Arbor, MI 48109-1070. | en_US |
dc.contributor.affiliationum | Department of Veterans Affairs, Ann Arbor Center of Excellence (COE), Serious Mental Illness Treatment Resource and Evaluation Center (SMITREC), Ann Arbor, Michigan ; Department of Psychiatry, University of Michigan Medical School, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Psychiatry, University of Michigan Medical School, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Veterans Affairs, Ann Arbor Center of Excellence (COE), Serious Mental Illness Treatment Resource and Evaluation Center (SMITREC), Ann Arbor, Michigan ; Department of Psychiatry, University of Michigan Medical School, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Veterans Affairs, Ann Arbor Center of Excellence (COE), Serious Mental Illness Treatment Resource and Evaluation Center (SMITREC), Ann Arbor, Michigan ; Department of Psychiatry, University of Michigan Medical School, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationother | Department of Veterans Affairs, Ann Arbor Center of Excellence (COE), Serious Mental Illness Treatment Resource and Evaluation Center (SMITREC), Ann Arbor, Michigan | en_US |
dc.contributor.affiliationother | Department of Veterans Affairs, Ann Arbor Center of Excellence (COE), Serious Mental Illness Treatment Resource and Evaluation Center (SMITREC), Ann Arbor, Michigan | en_US |
dc.identifier.pmid | 20629192 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/78075/1/1985_ftp.pdf | |
dc.identifier.doi | 10.1002/pds.1985 | en_US |
dc.identifier.source | Pharmacoepidemiology and Drug Safety | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.